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Previous studies have suggested that survival following surgery for colorectal cancer is poorer in the elderly. However, the findings
were inconsistent and none of the studies adjusted for case mix. The aim of this study was to establish whether there were
age-related differences in cancer (colorectal)-specific and non-cancer (colorectal)-related survival in patients undergoing elective
potentially curative resection for Dukes stage A/B colorectal cancer. One thousand and forty three patients who underwent elective
potentially curative resection for Dukes’ A/B colorectal cancer between 1991 and 1994 in 11 hospitals in Scotland were included in
the study. Ten year cancer-specific and non-cancer-related survival and the hazard ratios were calculated according to age groups
(o64; 65–74/474 years). On follow-up 273 patients died of their cancer and 328 died of non-cancer-related causes. At 10 years,
overall survival was 45%, cancer specific was 70% and non-cancer-related survival was 64%. On multivariate analysis of all factors,
age (HR 1.38, 95% CI 1.18–1.62, Po0.001), sex (HR 1.74, 95% CI 1.36–2.23, Po0.001), site (HR 1.42, 95% CI 1.11–1.81, Po0.01)
and Dukes’ stage (HR 1.71, 1.19–2.47, Po0.01) were independently associated with cancer-specific survival. On multivariate analysis
of all factors, age (HR 2.14, 1.84–2.49, Po0.001), sex (HR 1.43, 1.15–1.79, Po0.01) and deprivation (HR 1.30, 1.09–1.55, Po0.01)
were independently associated with non-cancer-related survival. The results of this study show that increasing age impacts negatively
both on cancer-specific and non-cancer-related survival following elective potentially curative resection for node-negative colorectal
cancer. However, the effect of increasing age is greater on the non-cancer-related survival. These results suggest that cancer-specific
and non-cancer-related mortality should be considered separately in survival analysis of these cancer patients.
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Colorectal cancer is the second commonest cause of cancer death
in Western Europe and North America. Many patients have
evidence of locally advanced or metastatic disease at the time of
initial presentation. Even in those undergoing apparently curative
resection, only half survive for 5 years (McArdle and Hole, 2002a).
It has long been recognised that there are a number of factors, in
addition to pathological stage, which contribute to poor outcome
following potentially curative surgery for colorectal cancer.
Age (Mulcahy et al, 1994; Shankar and Taylor, 1998; Colorectal
Cancer Collaborative Group, 2000), gender (McArdle et al, 2003),
deprivation (Hole and McArdle, 2002), tumour site (McArdle and
Hole, 2002b), emergency presentation (McArdle and Hole, 2004a)
and specialisation (McArdle and Hole, 2004b) have been shown to
impact on long-term survival in these patients.
However, whether old age is associated with poorer survival,
independent of these factors, remains unclear. The aim of this
study was to establish whether there were age-related differences
in cancer (colorectal)-specific and non-cancer (colorectal)-related
survival in patients undergoing elective potentially curative
resection for Dukes stage A/B colorectal cancer.
PATIENTS AND METHODS
One thousand and forty three patients who underwent an elective
potentially curative resection for Dukes A/B colorectal cancer
between 1 January 1991 and 31 December 1994 in 11 hospitals in
the central belt of Scotland were included in the study. Information
was abstracted from casenotes by two specially trained data
managers. Details included age, sex, deprivation category, site of
tumour, extent of tumour spread, the nature of surgery, post-
operative mortality, Dukes’ stage and adjuvant therapy. Data for
1991 and 1992 were collected retrospectively, and those for 1993
and 1994 were collected prospectively. There was no difference in
baseline characteristics of the patients between the two periods.
The extent of deprivation was defined using the Carstairs Index
(Carstairs and Morris, 1991), an area-based measure derived
from the 1991 census data based on the postcode of residents
at diagnosis. Carstairs divides the scores into a seven-point
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sscale ranging from most affluent (category 1) to most deprived
(category 7).
Tumours were classified according to the site colon or rectum. The
extent of tumour spread was assessed by conventional Dukes’ classi-
fication based on histological examination of the resected specimen.
Patients were deemed to have had a curative resection if the
surgeon considered that there was no macroscopic residual
tumour once resection had been completed.
Individual surgeons were defined as specialists or non-specialists
by a panel of six senior consultants and one of the authors (CSMcA).
Two of the six consultants were specialist colorectal surgeons
from teaching hospitals and four were district general hospital
consultants. These assessments were made without the knowledge of
the outcome and before any analysis was performed.
The approval was obtained for information on date and cause of
death to be checked with that received by the cancer registration
system through linkage with the Registrar General (Scotland).
Deaths up to the end of 2003 have been included in the analysis,
providing an average length of follow-up of 11 years (minimum
9 years, maximum 13 years).
Statistical analysis
The percentages of patients surviving 10 years were calculated
using the Kaplan–Meier technique. Comparison of the association
between age and other variables was made using the w
2 test or a
w
2 for trend where appropriate. The effect of age on cancer- and
non-cancer-related survival was examined using Cox’s propor-
tional hazards model. Analysis was performed using the SPSS
software package (SPSS Inc., Chicago, IL, USA).
RESULTS
Of the 1043 patients included in the analysis, 33% were aged 75 years
or over, 21% were socioeconomically deprived, 59% had colonic
tumours and 82% had Dukes’ B disease at the time of surgery. Two
hundred and seventy five (26%) patients were treated by a specialist
surgeon. Three percent of patients received adjuvant therapy.
The baseline characteristics of the patients included in the study
are shown in Table 1. With increasing age there was an increase in
the proportion of patients who had colonic tumours (Po0.001).
Few patients over the age of 74 years received adjuvant therapy
(Po0.001).
Two hundred and seventy three patients died of their cancer
and 328 died of non-cancer-related causes (Table 2). Of the
non-cancer-related deaths, 212 (65%) patients died of cardio-
vascular or respiratory disease. At 10 years, overall survival was
45%, cancer specific was 70% and non-cancer-related survival
was 64%. An increased proportion of cancer deaths at 10 years
was associated with increased Dukes’ stage (Po0.05) and non-
specialist surgeons (Po0.10). An increased proportion of non-
cancer-related deaths at 10 years was associated with older age
(Po0.001), female gender (Po0.05) and deprivation (Po0.10).
On univariate analysis, age (Po0.01), sex (Po0.001), site
(Po0.05) and Dukes’ stage (Po0.01) were significantly associated
with cancer-specific survival (Table 3). On multivariate analysis
of all factors, age (HR 1.38, 95% CI 1.18–1.62, Po0.001),
sex (HR 1.74, 95% CI 1.36–2.23, Po0.001), site (HR 1.42, 95% CI
1.11–1.81, Po0.01) and Dukes’ stage (HR 1.71, 1.19–2.47, Po0.01)
were independently associated with cancer-specific survival.
On univariate analysis, age (Po0.001), sex (Po0.05), depriva-
tion (Po0.01) and adjuvant therapy (Po0.10) were significantly
associated with non-cancer-related survival (Table 4). On multi-
variate analysis of all factors, age (HR 2.14, 1.84–2.49, Po0.001),
sex (HR 1.43, 1.15–1.79, Po0.01) and deprivation (HR 1.30,
1.09–1.55, Po0.01) were independently associated with non-
cancer-related survival.
The relationship between age and the hazard ratios for cancer
and non-cancer-related survival in patients with Dukes’ A/B
disease colon and rectum cancer is shown in Table 5. Compared
Table 1 Baseline characteristics of patients undergoing elective curative
resection for Dukes A/B colorectal cancer by age (n¼1043)
Age (years)
o64 years
n¼305 (29%)
65–74 years
n¼398 (38%)
474 years
n¼340 (33%) P-value
Female 143 (47%) 186 (47%) 184 (56%)
Male 162 (53%) 212 (53%) 156 (46%) 0.061
Depcat score
1, 2 53 (17%) 70 (18%) 69 (20%)
3, 4, 5 191 (63%) 245 (62%) 201 (59%)
6, 7 61 (20%) 83 (21%) 70 (21%) 0.625
Site
Colon 160 (52%) 228 (57%) 223 (66%)
Rectum 145 (48%) 170 (43%) 117 (37%) o0.001
Dukes’ stage
A 52 (17%) 76 (19%) 56 (17%)
B 253 (83%) 322 (81%) 284 (83%) 0.822
Specialisation
Specialist 76 (25%) 104 (27%) 95 (28%)
Non-specialist 223 (75%) 288 (73%) 240 (72%) 0.402
Adjuvant therapy
Yes 15 (5%) 16 (4%) 3 (1%)
No 290 (95%) 382 (96%) 337 (99%) o0.001
Table 2 Baseline characteristics of patients undergoing elective curative
resection for Dukes A/B colorectal cancer-by-cancer and non-cancer death
after 10 years follow-up
Cancer deaths
(n¼273)
Non-cancer
deaths (n¼328) P-value
Age
o64 years 68 (25%) 42 (13%)
65–74 years 109 (40%) 129 (39%)
474 years 96 (35%) 157 (48%) o0.001
Female 104 (38%) 153 (47%)
Male 169 (62%) 175 (53%) 0.035
Depcat score
1, 2 53 (19%) 45 (14%)
3, 4, 5 167 (62%) 206 (63%)
6, 7 53 (19%) 77 (24%) 0.052
Site
Colon 148 (54%) 192 (59%)
Rectum 125 (46%) 136 (41%) 0.287
Dukes’ stage
A 34 (13%) 61 (19%)
B 239 (87%) 267 (81%) 0.040
Specialisation
Specialist 61 (23%) 94 (27%)
Non-specialist 209 (77%) 226 (71%) 0.062
Adjuvant therapy
Yes 10 (4%) 6 (2%)
No 263 (96%) 322 (98%) 0.165
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swith patients under the age of 64 years who had colonic tumours,
those patients over the age of 74 years had a hazard ratio of
2.2 (Po0.01) and 5.4 (Po0.001) for cancer and non-cancer-related
survival, respectively. Compared with patients under the age
of 64 years who had rectal tumours, those patients over the age of
74 years had a hazard ratio of 5.1 (Po0.001) for non-cancer-
related survival.
DISCUSSION
The results of this study show that, in patients undergoing elective
potentially curative surgery for Dukes’ A/B colorectal cancer, with
10-year follow-up, more patients die of intercurrent disease, in
particular cardiovascular or respiratory disease, than die of cancer.
Increasing age, 75 years and over, impacted on cancer-related and
non-cancer-related survival. Although, it was notable that the
effect on non-cancer-related survival was approximately twice that
of cancer-related survival.
Given that colorectal cancer is a common cancer and that large
numbers of patients undergoing elective potentially curative
resection will die of intercurrent comorbid disease, the use of
overall survival as an end point may give misleading results.
Therefore, future studies on these patients should specify
the associations between factors and cancer-specific survival and
non-cancer-related survival separately to establish whether the
Table 3 The relationship between clinicopathological characteristics and cancer-specific survival in patients undergoing elective curative resection for
Dukes A/B colorectal cancer: univariate and multivariate analysis
Univariate analysis Multivariate analysis
Patients (n¼1043) Hazard ratio (95% CI) P-value Hazard ratio (95% CI) P-value
Age (o64/65–74/474 years) 305/398/340 1.29 (1.11–1.50) 0.001 1.38 (1.18–1.62) o0.001
Sex (female/male) 513/530 1.75 (1.37–2.23) o0.001 1.74 (1.36–2.23) o0.001
Deprivation (1–2/3–5/6–7)
a 192/637/214 0.98 (0.81–1.19) 0.840 0.322
Site (colon/rectum) 611/432 1.28 (1.01–1.62) 0.044 1.42 (1.11–1.81) 0.006
Dukes’ stage (A/B) 184/859 1.70 (1.19–2.44) 0.004 1.71 (1.19–2.47) 0.004
Specialisation (yes/no) 275/751 1.27 (0.95–1.69) 0.101 0.104
Adjuvant therapy (yes/no) 34/1009 0.94 (0.50–1.77) 0.845 0.750
aIndividual deprivation categories were used in the statistical analysis.
Table 4 The relationship between clinicopathological characteristics and non-cancer survival in patients undergoing elective curative resection for Dukes
A/B colorectal cancer: univariate and multivariate analysis
Univariate analysis Multivariate analysis
Patients (n¼1043) Hazard ratio (95% CI) P-value Hazard ratio (95% CI) P-value
Age (o64/65–74/474years) 305/398/340 2.11 (1.82–2.45) o0.001 2.14 (1.84–2.49) o0.001
Sex (female/male) 513/530 1.32 (1.06–1.64) 0.012 1.43 (1.15–1.79) 0.002
Deprivation (1–2/3–5/6–7)
a 192/637/214 1.30 (1.09–1.53) 0.003 1.30 (1.09–1.55) 0.003
Site (colon/rectum) 611/432 1.11 (0.88–1.37) 0.407 0.094
Dukes’ stage (A/B) 184/859 1.07 (0.81–1.42) 0.676 0.346
Specialisation (yes/no) 275/751 0.89 (0.70–1.13) 0.332 0.548
Adjuvant therapy (yes/no) 34/1009 2.11 (0.96–4.87) 0.061 0.302
aIndividual deprivation categories were used in the statistical analysis.
Table 5 Hazard ratios for cancer-specific and non-cancer survival at 10 years in patients undergoing elective curative resection for Dukes A/B colorectal
cancer by age
Cancer specific (deaths¼148) Non-cancer (deaths¼192)
Colon (n¼611) Hazard ratio (95% CI) P-value Hazard ratio (95% CI) P-value
Age
o64 years 1 0.004 1 o0.001
65–74 years 1.71 (1.09–2.69) 0.019 3.01 (1.85–4.91) o0.001
474 years 2.16 (1.38–3.37) 0.001 5.39 (3.36–8.64) o0.001
Cancer specific (deaths¼125) Non-cancer (deaths¼136)
Rectum (n¼432) Hazard ratio (95%CI) P-value Hazard ratio (95%CI) P-value
Age
o64 years 1 0.286 o0.001
65–74 years 1.28 (0.85–1.94) 0.237 3.02 (1.84–4.50) o0.001
474years 1.42 (0.90–2.25) 0.132 5.09 (3.08–8.41) o0.001
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sfactor impacts equally on cancer-specific and non-cancer-related
survival.
The results of this study have a number of important
implications. First, with the introduction of screening programmes
for colorectal cancer and the consequent increase in early stage
disease, it is likely that the issue of age-related comorbid death will
become a major issue in these patients. If this were proven to be
the case, it would be important that within screening programmes
for colorectal cancer, patients should also be screened for the
presence of comorbid disease. For example, in patients aged of
75 years and over undergoing potentially curative resection for
node-negative colorectal cancer, it would be important not only to
treat the cancer, but also the comorbid disease, in particular it
would appear from this study that this is cardiovascular or
respiratory disease.
In the context of this study, it is of interest that a strong
association between colorectal cancer and vascular disease has
been reported (Chan et al, 2006, 2007). This may be because of the
shared environmental risk factors such as age, smoking, diabetes
mellitus and obesity (Giovannucci and Martı ´nez, 1996; Larsson
et al, 2005; McMillan et al, 2006). It has also been hypothesised
that these diseases develop through a common pathway of chronic
inflammatory disease (Chan et al, 2006, 2007). Indeed, there is
evidence that such environmental factors are directly associated
with C-reactive protein concentrations, the prototypical marker of
the systemic inflammatory response, in apparently healthy subjects
(Koenig et al, 1999; Hutchinson et al, 2000; Chenillot et al, 2000:
Wong et al, 2001). However, it remains to be determined whether
the systemic inflammatory response impacts equally on cancer-
specific and non-cancer-related survival in patients undergoing
potentially curative surgery for colorectal cancer.
In summary, the results of this study show that although age
impacts both on cancer-specific and non-cancer-related survival
following elective potentially curative resection for node-negative
colorectal cancer, the effect is greater on non-cancer-related
survival. These results suggest that cancer-specific and non-
cancer-related deaths should be considered separately in survival
analysis of these patients.
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